Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen L Reeves

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Hepatology (Baltimore, Md.)|September 11, 2022
c-Rel-dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesisJack Leslie, Jill E Hunter, Amy Collins, et al.
Hepatology (Baltimore, Md.)|March 12, 2024
Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver diseaseAlfredo Marchetti, Serena Pelusi, Alessio Marella, et al.
Liver Cancer|May 14, 2020
Development of a Novel Inflammation-Based Index for Hepatocellular CarcinomaStephen Lam Chan, Lin-Lee Wong, Kwan-Chee Allen Chan, et al.
Cancers|April 3, 2021
A <i>PDCD1</i> Role in the Genetic Predisposition to NAFLD-HCC?Nardeen Eldafashi, Rebecca Darlay, Ruchi Shukla, et al.
Hepatology (Baltimore, Md.)|November 19, 2011
Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver diseaseLars P Bechmann, Amalia Gastaldelli, Diana Vetter, et al.
Nature Communications|July 1, 2014
TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver diseaseYang-Lin Liu, Helen L Reeves, Alastair D Burt, et al.
Journal of Clinical and Experimental Hepatology|February 7, 2020
Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom CohortMunirah Alsaleh, Zoe Leftley, Thomas A Barbera, et al.
The Journal of Clinical Investigation|October 4, 2019
Selective DNA-PKcs inhibition extends the therapeutic index of localized radiotherapy and chemotherapyCatherine E Willoughby, Yanyan Jiang, Huw D Thomas, et al.
Journal of Hepatology|January 29, 2013
Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosisLars P Bechmann, Diana Vetter, Junichi Ishida, et al.
Liver Cancer|January 2, 2023
Sulfatase-2 from Cancer Associated Fibroblasts: An Environmental Target for Hepatocellular Carcinoma?Marco Y W Zaki, Sari F Alhasan, Ruchi Shukla, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Hepatology (Baltimore, Md.)|September 11, 2022
c-Rel-dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesisJack Leslie, Jill E Hunter, Amy Collins, et al.
Hepatology (Baltimore, Md.)|March 12, 2024
Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver diseaseAlfredo Marchetti, Serena Pelusi, Alessio Marella, et al.
Liver Cancer|May 14, 2020
Development of a Novel Inflammation-Based Index for Hepatocellular CarcinomaStephen Lam Chan, Lin-Lee Wong, Kwan-Chee Allen Chan, et al.
Cancers|April 3, 2021
A <i>PDCD1</i> Role in the Genetic Predisposition to NAFLD-HCC?Nardeen Eldafashi, Rebecca Darlay, Ruchi Shukla, et al.
Hepatology (Baltimore, Md.)|November 19, 2011
Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver diseaseLars P Bechmann, Amalia Gastaldelli, Diana Vetter, et al.
Nature Communications|July 1, 2014
TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver diseaseYang-Lin Liu, Helen L Reeves, Alastair D Burt, et al.
Journal of Clinical and Experimental Hepatology|February 7, 2020
Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom CohortMunirah Alsaleh, Zoe Leftley, Thomas A Barbera, et al.
The Journal of Clinical Investigation|October 4, 2019
Selective DNA-PKcs inhibition extends the therapeutic index of localized radiotherapy and chemotherapyCatherine E Willoughby, Yanyan Jiang, Huw D Thomas, et al.
Journal of Hepatology|January 29, 2013
Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosisLars P Bechmann, Diana Vetter, Junichi Ishida, et al.
Liver Cancer|January 2, 2023
Sulfatase-2 from Cancer Associated Fibroblasts: An Environmental Target for Hepatocellular Carcinoma?Marco Y W Zaki, Sari F Alhasan, Ruchi Shukla, et al.
Pageof 7